IPCA Laboratories Ltd.: Malnutrition trials

The registry lists 14 Malnutrition studies with IPCA Laboratories Ltd. as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed ConditionsCompletedNCT01884909Phase 1
• Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed ConditionCompletedNCT01831687Phase 1
• Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed ConditionCompletedNCT01831674Phase 1
• Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed ConditionsCompletedNCT01827878Phase 1
• Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed ConditionCompletedNCT01749228Phase 1
• Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed ConditionCompletedNCT01744873Phase 1
• Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed ConditionCompletedNCT01735383Phase 1
• Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed ConditionCompletedNCT01735344Phase 1
• Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed ConditionCompletedNCT01722110Phase 1
• Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed ConditionCompletedNCT01618825Phase 1
• Bioequivalence Study of Risperidone Tablet 1 mg Under Fed ConditionCompletedNCT01618760Phase 1
• Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed ConditionCompletedNCT01603186Phase 1
• Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed ConditionCompletedNCT01578265Phase 1
• Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed ConditionCompletedNCT01567501Phase 1